These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 30542715

  • 1. Inhibition of miR‑194 suppresses the Wnt/β‑catenin signalling pathway in gastric cancer.
    Peng Y, Zhang X, Lin H, Deng S, Huang Y, Qin Y, Feng X, Yan R, Zhao Y, Cheng Y, Wei Y, Wang J, Chen W, Fan X, Ashktorab H, Smoot D, Meltzer SJ, Li S, Zhang Z, Jin Z.
    Oncol Rep; 2018 Dec; 40(6):3323-3334. PubMed ID: 30542715
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. miR‑483‑5p promotes growth, invasion and self‑renewal of gastric cancer stem cells by Wnt/β‑catenin signaling.
    Wu K, Ma L, Zhu J.
    Mol Med Rep; 2016 Oct; 14(4):3421-8. PubMed ID: 27511210
    [Abstract] [Full Text] [Related]

  • 6. SUFU mediates EMT and Wnt/β-catenin signaling pathway activation promoted by miRNA-324-5p in human gastric cancer.
    Peng Y, Zhang X, Lin H, Deng S, Qin Y, Yuan Y, Feng X, Wang J, Chen W, Hu F, Yan R, Zhao Y, Cheng Y, Wei Y, Fan X, Ashktorab H, Smoot D, Li S, Meltzer SJ, Jin Z.
    Cell Cycle; 2020 Oct; 19(20):2720-2733. PubMed ID: 33017570
    [Abstract] [Full Text] [Related]

  • 7. Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway.
    Zhang J, Zhang K, Hou Y.
    Mol Med Rep; 2020 Aug; 22(2):687-696. PubMed ID: 32468065
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Non‑coding RNAs that regulate the Wnt/β‑catenin signaling pathway in gastric cancer: Good cop, bad cop? (Review).
    Shao Z, Gao D, Chen L, Ding W, Yu Q.
    Oncol Rep; 2020 Oct; 44(4):1314-1321. PubMed ID: 32945460
    [Abstract] [Full Text] [Related]

  • 10. SMG-1 inhibition by miR-192/-215 causes epithelial-mesenchymal transition in gastric carcinogenesis via activation of Wnt signaling.
    Zhang X, Peng Y, Huang Y, Yang M, Yan R, Zhao Y, Cheng Y, Liu X, Deng S, Feng X, Lin H, Yu H, Chen S, Zhao Z, Li S, Li K, Wang L, Wei Y, He Z, Fan X, Meltzer SJ, Li S, Jin Z.
    Cancer Med; 2018 Jan; 7(1):146-156. PubMed ID: 29239144
    [Abstract] [Full Text] [Related]

  • 11. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
    Luo X, Ye S, Jiang Q, Gong Y, Yuan Y, Hu X, Su X, Zhu W.
    Int J Oncol; 2018 Aug; 53(2):904-914. PubMed ID: 29916529
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N, Du P, Zhang A, Shen F, Su J, Pu P, Wang T, Zjang J, Kang C, Zhang Q.
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. RORβ suppresses the stemness of gastric cancer cells by downregulating the activity of the Wnt signaling pathway.
    Wen Z, Chen M, Guo W, Guo K, Du P, Fang Y, Gao M, Wang Q.
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278502
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression.
    Sun J, Ma Q, Shu C, Xiong J, Li B, Wu J, Zhang S, Li J, Liu J, Wang J.
    Int J Oncol; 2021 Jan; 58(1):45-56. PubMed ID: 33367931
    [Abstract] [Full Text] [Related]

  • 18. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.
    Huang T, Kang W, Zhang B, Wu F, Dong Y, Tong JH, Yang W, Zhou Y, Zhang L, Cheng AS, Yu J, To KF.
    Mol Cancer; 2016 Jan 22; 15():9. PubMed ID: 26801246
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.